Skip to main content

Waters Corporation guidance

  • WAT · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$455.58+0.48%Close 17 Nov 2026 · Market value $44.31B

In its results release of 3 Nov 2026 (Q3 FY2026), Waters Corporation gave 7 forecasts in figures, among them revenue of $1.80B to $1.82B for Q4 FY2026. Over the last two years, results landed above the company's own last range 6 of 8 times, within it 2 and below it 0.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Latest guidance given with Q3 FY2026 results, 3 Nov 2026

MeasurePeriodGuidanceAs stated
RevenueQ4 FY2026$1.80B to $1.82BTotal Company reported revenue for the fourth quarter of 2026 is expected to be in the range of $1.801 billion to $1.819 billion.
Organic revenue growthQ4 FY2026+7% to +9%The Company expects fourth quarter 2026 organic constant currency revenue growth to be in the range of 7.0% to 9.0%
EPS · AdjustedQ4 FY2026$4.58 to $4.68The Company expects fourth quarter 2026 adjusted EPS to be in the range of $4.58 to $4.68, which represents 1% to 3% year-over-year adjusted EPS growth.
RevenueFY2026$6.48B to $6.50BTotal Company reported revenue for full-year 2026 is expected to be in the range of $6.479 billion to $6.497 billion.
Organic revenue growth · RaisedFY2026+9.1% to +9.7%The Company is raising its full-year 2026 organic constant currency revenue growth guidance to the range of 9.1% to 9.7%
EPS · AdjustedFY2026$14.60 to $14.70The Company is updating its full-year 2026 adjusted EPS guidance to the range of $14.60 to $14.70, which represents 11% to 12% year-over-year adjusted EPS growth and is 13% to 14% on a constant currency basis.
EPS growth · AdjustedFY2026+13% to +14%The Company is updating its full-year 2026 adjusted EPS guidance to the range of $14.60 to $14.70, which represents 11% to 12% year-over-year adjusted EPS growth and is 13% to 14% on a constant currency basis.

Source: the company's earnings release.

Guidance against results above 6 · within 2 · below 0

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
RevenueFY2026$6.48B to $6.50BRaised twice—To come
Organic revenue growthFY2026+9.1% to +9.7%Raised twice—To come
EPS · AdjustedFY2026$14.60 to $14.70Raised 3 times—To come
EPS growth · AdjustedFY2026+13% to +14%Raised twice—To come
RevenueQ4 FY2026$1.80B to $1.82BGiven once—To come
Organic revenue growthQ4 FY2026+7% to +9%Given once—To come
EPS · AdjustedQ4 FY2026$4.58 to $4.68Given once—To come
RevenueQ3 FY2026$1.75B to $1.76BGiven once$1.77BAbove the range
EPS · AdjustedQ3 FY2026$3.95 to $4.05Given once$4.10Above the range
RevenueQ2 FY2026$1.62B to $1.63BGiven once$1.65BAbove the range
EPS · AdjustedQ2 FY2026$2.95 to $3.05Given once$3.05Within the range
RevenueQ1 FY2026$1.20B to $1.21BGiven once$1.27BAbove the range
EPS · AdjustedQ1 FY2026$2.25 to $2.35Given once$2.70Above the range
EPS · AdjustedQ4 FY2025$4.45 to $4.55Given once$4.53Within the range
EPS · AdjustedQ3 FY2025$3.15 to $3.25Given once$3.40Above the range

WAT in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.